ClinicalTrials.Veeva

Menu

Measurement of Anterior Chamber Cell Grading Using Ocular Coherence Tomography

Rutgers The State University of New Jersey logo

Rutgers The State University of New Jersey

Status

Terminated

Conditions

Uveitis

Treatments

Other: Eye Exam
Device: Optical Coherence Tomography (OCT)

Study type

Interventional

Funder types

Other

Identifiers

NCT02907814
Pro20160000585

Details and patient eligibility

About

Optical Coherence Tomography (OCT) is routinely used in ophthalmic clinical practice. It uses infrared light to image patient's eyes. Some patients, such as those with an inflammatory disease called uveitis or those who have just undergone cataract surgery, have intraocular inflammation. This intraocular inflammation commonly manifests as cells that can be seen on routine microscopic clinical examination. However, the only currently available method to quantify this intraocular inflammation is by manually counting on the microscopic clinical examination. The investigators plan to use the OCT machine to image patient's eyes. The investigators will then use the images obtained from the OCT to objectively quantify the degree of intraocular inflammation.

Enrollment

6 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age over 18 years old

  • Intervention Arm:

    • Active anterior chamber inflammation in at least one eye as diagnosed by clinical exam
    • One of the following: 1) diagnosis of uveitis OR 2) undergone cataract extraction surgery within the previous 30 days
  • Control Arm:

    • No active intraocular inflammation based on clinical exam

Exclusion criteria

  • Corneal opacities in the affected eye
  • Anyone judged unable to understand or consent to study participation

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

6 participants in 2 patient groups

Uveitis and Cataract Imaging Group
Experimental group
Description:
Subjects will undergo up to three optical coherence tomography scans.
Treatment:
Device: Optical Coherence Tomography (OCT)
Control
Experimental group
Description:
Control subjects will undergo a brief, non-contact eye exam and then undergo up to three optical coherence tomography scans.
Treatment:
Other: Eye Exam
Device: Optical Coherence Tomography (OCT)

Trial documents
2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems